MedPath

The effect of dexmedetomidine on postoperative analgesia in patients undergoing femoral fracture surgery

Phase 3
Conditions
Analgesia in femoral fractures.
Acute pain, not elsewhere classified
G89.1
Registration Number
IRCT20170515033986N4
Lead Sponsor
Oroumia University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
All
Target Recruitment
80
Inclusion Criteria

Patients with femoral fracture surgery under spinal anesthesia
Patients with ASA I and ASA II
Age between 25 to 75 years

Exclusion Criteria

Any contraindication for spinal anesthesia
Obesity (body mass index more than 35 kg/m2)
Local infection at the injection site in the groin
Previous surgery at the injection site
Injecting drug addicts
Receiving any type of analgesic two hours before surgery
Mental and psychological disorders
Multi-trauma fractures
A History of severe heart disease
A history of kidney and respiratory diseases
Liver disease
Pregnancy
Hematologic disorders

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Duration of analgesia. Timepoint: The duration of analgesia until the onset of pain felt by the patient in 24 hours after surgery. Method of measurement: timing.;Prescribing an analgesic. Timepoint: Prescribing an analgesia in recovery, 2, 6, 12 and 24 hours after surgery. Method of measurement: Patient request.
Secondary Outcome Measures
NameTimeMethod
Time to Prescription an analgesic. Timepoint: 24 hours after surgery. Method of measurement: Timing.;Pain severity. Timepoint: In recovery, 2, 6, 12 and 24 hours after surgery. Method of measurement: Visual Analog Scale (VAS).;Complications of Iliaca fascia block. Timepoint: In recovery, 2, 6, 12 and 24 hours after surgery. Method of measurement: Clinical examination.
© Copyright 2025. All Rights Reserved by MedPath